Upexi Inc. (GRVI)
NASDAQ: GRVI
· Real-Time Price · USD
4.95
0.35 (7.61%)
At close: Aug 19, 2022, 6:00 AM
Company Description
Grove, Inc., through its subsidiaries, engages in developing, producing, marketing, and selling raw materials, white label products, and end consumer products containing the industrial hemp plant extract, cannabidiol.
The company serves consumer markets, including the botanical, beauty care, pet care, and functional food sectors.
It also operates annual tradeshow related to the CBD industry in the United States.
The company was incorporated in 2018 and is headquartered in Henderson, Nevada.
Upexi Inc.
| Country | United States |
| IPO Date | Jun 24, 2021 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 122 |
| CEO | Allan J. Marshall |
Contact Details
Address: 1710 Whitney Mesa Drive Henderson, Nevada United States | |
| Website | https://groveinc.io |
Stock Details
| Ticker Symbol | GRVI |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| CIK Code | 0001775194 |
| CUSIP Number | 39959A106 |
| ISIN Number | US39959A1060 |
| Employer ID | 83-3378978 |
| SIC Code | 2833 |
Key Executives
No executives data available.Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 15, 2025 | 8-K | Current Report |
| Aug 13, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| Aug 11, 2025 | S-1 | Filing |
| Aug 08, 2025 | 8-K | Current Report |
| Aug 08, 2025 | DEF 14A | Filing |
| Aug 08, 2025 | S-1/A | [Amend] Filing |
| Aug 05, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| Aug 01, 2025 | 8-K | Current Report |
| Jul 30, 2025 | 4 | Filing |
| Jul 30, 2025 | SCHEDULE 13G | Filing |